Key Market Indicators
Sales of blood and blood forming organs medicines in Costa Rica are estimated to hit $34.1 million by 2026. This is up 1.4% annually on average since 2012. In 2021, the country was ranked 28th, behind Latvia which had sales of $29.9 million. Germany, Italy and South Korea were the top three countries in the ranking. Meanwhile, the prevalence of anemia in Costa Rica is expected to stand at 508 hospital discharges by 2026. This is a 2.4% decrease on average each year since 2002. In 2021, the nation was ranked 30th, behind Latvia which had 564 hospital discharges. Germany, the UK and Poland were the top three countries in the ranking.
